BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32450089)

  • 1. A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities.
    Serper M; Shaked A; Olthoff KM; Hoteit M; Appolo B; Reddy KR
    J Hepatol; 2020 Sep; 73(3):708-709. PubMed ID: 32450089
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID 19 and the Liver.
    Shukla A; Mohanka R
    J Assoc Physicians India; 2020 Nov; 68(11):11-12. PubMed ID: 33187029
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
    Ji D; Xu J; Qin E; Zhang D; Cheng G; Wang Y; Lau G
    J Hepatol; 2020 Sep; 73(3):718-719. PubMed ID: 32387073
    [No Abstract]   [Full Text] [Related]  

  • 4. Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy.
    Di Giorgio A; Nicastro E; Speziani C; De Giorgio M; Pasulo L; Magro B; Fagiuoli S; D' Antiga L
    J Hepatol; 2020 Sep; 73(3):702-705. PubMed ID: 32413378
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in cirrhosis hospitalizations during the COVID-19 pandemic.
    Gaspar R; Liberal R; Branco CC; Macedo G
    Dig Liver Dis; 2020 Sep; 52(9):942-943. PubMed ID: 32680758
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19: An Overview of Worldwide Recommendations for Management of Patients With Liver Diseases or Liver Transplantation.
    Perazzo H; Piedade J; Castro R; Pinto L; Veloso VG; Grinsztejn B; Pereira G; Fernandes FF
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2381-2384.e10. PubMed ID: 32407967
    [No Abstract]   [Full Text] [Related]  

  • 7. We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?
    Bloom PP; Pasricha TS; Viveiros K
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2384-2385. PubMed ID: 32425706
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The liver in times of COVID-19: What hepatologists should know.
    Ridruejo E; Soza A
    Ann Hepatol; 2020; 19(4):353-358. PubMed ID: 32425991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):217-221. PubMed ID: 32306655
    [No Abstract]   [Full Text] [Related]  

  • 11. Digestive and Liver Diseases and the COVID-19 Pandemic.
    de Franchis R
    Dig Liver Dis; 2020 Aug; 52(8):799. PubMed ID: 32713475
    [No Abstract]   [Full Text] [Related]  

  • 12. Let's not forget our COVID-19-free cirrhotic patients!
    Viganò M; Carbone M
    Liver Int; 2020 Jun; 40(6):1508-1509. PubMed ID: 32329551
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes.
    Liu F; Long X; Ji G; Zhang B; Zhang W; Zhang Z; Chen X
    J Infect; 2020 Aug; 81(2):e178-e180. PubMed ID: 32562796
    [No Abstract]   [Full Text] [Related]  

  • 14. Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology.
    Arrese M
    Ann Hepatol; 2020; 19(4):339-340. PubMed ID: 32482463
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictor of poor prognosis of COVID-19 patients - liver injury.
    Fu T; Deng M; Wang X; Yang F
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):873-876. PubMed ID: 32643980
    [No Abstract]   [Full Text] [Related]  

  • 16. [COVID-19 and Pulmonology: New Challenges and Opportunities].
    Clérigo V; Duarte P
    Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review.
    Taher M; Miroliaee A; Ebrahimi Daryani N; Alborzi Avanaki F; Aletaha N; Nasiri-Toosi M; Dashti H; Basirat V; Jafarian A
    Arch Iran Med; 2020 Oct; 23(10):713-717. PubMed ID: 33107315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical insight into the involvement of gut and liver by COVID-19.
    Abbas Z; Zaheer R
    J Pak Med Assoc; 2020 Jun; 70(6):952-953. PubMed ID: 32810083
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver Transplantation in an ICU Dominated by COVID-19.
    Cardoso FS
    Liver Transpl; 2020 Aug; 26(8):1064-1065. PubMed ID: 32246576
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges and Ethical Considerations for Trainees and Attending Physicians During the COVID-19 Pandemic.
    Hai S; Baroutjian A; Elkbuli A
    J Am Coll Surg; 2020 Aug; 231(2):301-302. PubMed ID: 32487426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.